ABSTRACT
OBJECTIVE: Coronary and chronic lung diseases have become a common association. This comorbidity has been generically considered by most of the operative risk scores, but its functional severity has seldom been addressed by these models. Our objective was to analyze its prognostic relevance considering preoperative pulmonary function parameters. METHODS: All patients undergoing CABG from May 1993 to December 2004 have been reviewed. One thousand four hundred and twelve patients with preoperative pulmonary function test were finally included in the study. Obstructive lung disease was defined when FEV1/FVC<0.7. In-hospital mortality and complication rate related to chronic obstructive pulmonary disease and its degree of severity (FEV1%) were assessed. Logistic regression analysis was used to determine independent predictors of mortality. RESULTS: A pathologic preoperative pulmonary function test was found in 39% of patients: obstructive in 26% (FEV1/FVC<0.7), restrictive in 9% and combined obstructive-restrictive in 4%. In-hospital mortality was higher in patients with abnormal test: 6.5% versus 0.9% (p<0.001). Mortality was clearly related with the severity of lung disease: 0.9% in patients with FEV1: >80%, 0.4% in FEV1: 60-80%, 10.8% in FEV1: 40-59% and 54% in FEV1: <40%. In the latter group, other intercurrent prognostic factors were observed. Patients with FEV1<60% had higher mortality than those with FEV1>60%: 24.6% versus 1.4% (p<0.001). Chronic obstructive lung disease was not an independent predictor of mortality but FEV1< or =60% was significantly associated with death. CONCLUSIONS: This study on chronic lung comorbidity in CABG patients shows that this association can be of deleterious prognostic value but this effect is directly related to the degree of functional severity. Preoperative FEV1<60% must be considered as a primary prognostic factor in patients undergoing CABG procedures.
Subject(s)
Coronary Artery Bypass/mortality , Coronary Disease/surgery , Pulmonary Disease, Chronic Obstructive/complications , Aged , Area Under Curve , Cardiopulmonary Bypass/methods , Coronary Artery Bypass/methods , Coronary Disease/complications , Coronary Disease/physiopathology , Female , Hospital Mortality , Humans , Intraoperative Period , Logistic Models , Male , Middle Aged , Prognosis , Pulmonary Disease, Chronic Obstructive/physiopathology , Respiratory Function Tests , Retrospective Studies , Risk AssessmentABSTRACT
OBJECTIVE: Several studies have demonstrated favorable results despite patient-prosthesis mismatch after aortic valve replacement with the use of third generation prostheses. Our aim was to determine whether this mismatch is always tolerable. METHODS: A clinical-echocardiographic study has been performed in 339 consecutive patients who underwent aortic valve replacement because of aortic stenosis. In-hospital outcome and left ventricular mass index regression (1st month-1st year) were analyzed in the presence or absence of mismatch (indexed effective orifice area < or =0.85cm(2)/m(2)). The influence of high degrees of preoperative left ventricular mass on in-hospital mortality has also been evaluated. Left ventricular mass index was considered increased if the calculated value was over the superior quartile of the frequency distribution of all the values observed in both sexes. RESULTS: Mismatch was found in 38% of the patients. In the absence of mismatch, the absolute mass regression was proportional to the preoperative left ventricular mass. This regression was higher in patients with increased left ventricular mass indexed (vs not increased): -38.0+/-7.8 vs -8.8+/-4.7g/m(2), p<0.01 (1st month) and -67.7+/-16.9vs -23.5+/-6.7g/m(2), p<0.05 (1st year). Mass regression was impaired in the presence of mismatch, particularly, in patients with previously increased left ventricular mass: -8.2+/-11.6 vs -5.6+/-6.3g/m(2) (p=0.83) and -24.6+/-12.6 vs -11.7+/-10.5g/m(2) (p=0.54). This worse regression was reflected on a 100% incidence of residual hypertrophy at follow-up (1st month-1st year). In the presence of mismatch, increased ventricular mass was associated with higher mortality: 14.7% vs 2.1% (p<0.01). In the absence of mismatch, ventricular mass was not associated with mortality: 4.1 vs 2.5% (p=0.55). CONCLUSIONS: In patients with severe ventricular hypertrophy it may be important to elude patient-prosthesis mismatch to avoid a significant increase in mortality and improve ventricular mass regression. Mismatch may be tolerable in those patients with lesser degree of hypertrophy.